July 10, 2025
| Today’s news and insights for medtech leaders
The year kicked off with a handful of acquisitions from top companies. Dealmaking has since slowed amid economic uncertainty but could be poised for a rebound.
|
The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid regurgitation, in which blood can leak backward into the heart.
|
The former Masimo executive will lead strategy development to support the transition to BD’s revised business structure over the next several months.
|
The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.
|
Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small study met safety and performance goals.
|
|
Pharma companies are increasingly relying on outsourcing to enhance trial efficiency. Learn how a hybrid approach can prevent business disruption and offer greater agility in this webinar.
|
|
From Our Library
Playbook
Custom content for Medrio
|
Playbook
Custom content for Medrio
|
View all resources
What We're Reading
Fierce Biotech
|
Healthcare Dive
|
| 
